The scarce number of patients, the retrospective nature of the clinical study, the lack of experiments demonstrating that exogenous MMP-2 is also beneficial for lung inflammation and measurement of airway hyperresponsiveness using only enhanced pause are limitations of the current study. Here, MMP2 is linked to inflammation.